XOMA Corp Share Price Nasdaq
Equities
US98419J1079
Biotechnology & Medical Research
Sales 2024 * | 14M 1.17B | Sales 2025 * | 23.57M 1.96B | Capitalization | 296M 24.67B |
---|---|---|---|---|---|
Net income 2024 * | -27M -2.25B | Net income 2025 * | -19M -1.58B | EV / Sales 2024 * | 21.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 12.6 x |
P/E ratio 2024 * |
-10.7
x | P/E ratio 2025 * |
-15.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.58% |
Managers | Title | Age | Since |
---|---|---|---|
Owen Hughes
CEO | Chief Executive Officer | 49 | 01/23/01 |
Thomas Burns
DFI | Director of Finance/CFO | 50 | 14/06/14 |
Bradley Sitko
CIO | Chief Investment Officer | 43 | 03/23/03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Heather Franklin
BRD | Director/Board Member | 58 | 06/21/06 |
Chairman | 68 | 26/10/26 | |
Joseph Limber
BRD | Director/Board Member | 71 | 12/12/12 |
1st Jan change | Capi. | |
---|---|---|
-1.18% | 103B | |
+8.77% | 101B | |
+4.40% | 23.07B | |
-12.22% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.20% | 16.94B | |
+6.85% | 14.07B | |
+39.15% | 12.35B |